Bharat Biotech Cuts Malaria Vaccine Price by 40% in UNICEF Pact
Bharat Biotech has reduced the price of its malaria vaccine Mosquirix by 40% following an agreement supported by UNICEF and Gavi. This price cut aims to make the vaccine more affordable and boost immunization efforts against malaria, particularly in Africa. The move is expected to enhance access to the vaccine and support global malaria control initiatives.
The Hindu·



